Morgan Stanley maintains Colgate-Palmolive at Overweight, raises price target to $111 from $104

What happened

Morgan Stanley maintained its Overweight rating on Colgate-Palmolive and raised its price target to $111 from $104. The new target is 6.7% higher and implies 16.5% upside from the October 30 closing price of $95.29.

Confirmed

Global impact / market context

A higher target signals that Morgan Stanley sees more potential value in Colgate-Palmolive shares than before, while keeping its positive rating unchanged. If investors act on that view, buying could support the share price, but the target is an analyst estimate, not a guaranteed outcome.

Analyst inference

Five other recent analyst notes cited in the article set targets between $95 and $108, placing Morgan Stanley’s $111 target above that range. This indicates differing valuation views; those targets alone do not establish changes in Colgate-Palmolive’s sales, costs, or cash generation.

Analyst inference

What to watch

1. Compare upcoming analyst targets and ratings with Morgan Stanley’s $111 target to see whether other firms adopt similarly positive views or maintain more cautious valuations. Analyst inference
2. Watch Colgate-Palmolive’s reported sales and costs in future results; improving or weakening business performance could support or challenge the assumptions behind higher share valuations. Analyst inference
3. The article reports a 16.5% implied upside from the October 30 close, but does not state that the share price has moved toward the target. Confirmed

Evidence

• Original source link unavailable